EnPlusOne Biosciences Welcomes Jim Weissman to Board
28 May 2026 //
BUSINESSWIRE
EnPlusOne Advances ezRNA Platform for Next-Gen RNA Therapeutics
12 May 2026 //
BUSINESSWIRE
EnPlusOne Biosciences To Present New Data at TIDES USA
15 May 2025 //
BUSINESSWIRE
EnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO
17 Apr 2025 //
BUSINESSWIRE
EnPlusOne Biosciences Raises $10M in Financing
19 Feb 2025 //
BUSINESSWIRE

Market Place
Sourcing Support